查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
消化性潰瘍治療藥的全球市場 - 成長，未來展望，競爭分析(2022年～2030年)
市場調查報告書
商品編碼
1180740

消化性潰瘍治療藥的全球市場 - 成長，未來展望，競爭分析(2022年～2030年)

Peptic Ulcer Drugs Market - Growth, Future Prospects and Competitive Analysis, 2022 - 2030
出版日期: | 出版商: Acute Market Reports | 英文 117 Pages | 商品交期: 最快1-2個工作天內

價格

消化性潰瘍，是胃，小腸，食道下部的粘膜發生伴隨疼痛的潰瘍之一。胃幽門桿菌感染增加，壓力和飲食等生活方式的變化，抽煙率增加，Naproxen，Ibuprofen，阿斯匹林，酮洛芬等非類固醇消炎劑的過剩使用，診斷技術的提高，及比外科手術更偏好藥物使用等幾個要素，牽引全球消化性潰瘍治療藥市場成長。

本報告提供全球消化性潰瘍治療藥市場相關調查，市場趨勢，競爭資訊，市場區隔分析，新興趨勢，技術分析，企業簡介等資訊。

目錄

第1章 序文

  • 報告概要
  • 市場區隔
  • 調查手法

第2章 摘要整理

  • 市場概述:全球消化性潰瘍治療藥市場
  • 全球消化性潰瘍治療藥市場:各藥物(2021年)
  • 全球消化性潰瘍治療藥市場:各地區(2021年)
  • 富有魅力的投資提案:各地區(2021年)

第3章 消化性潰瘍治療藥市場:競爭分析

  • 主要的消化性潰瘍治療藥市場供應商的市場定位
  • 消化性潰瘍治療藥市場供應商的採用策略
  • 主要的產業策略
  • 階層分析:2021年對2030年

第4章 消化性潰瘍治療藥市場:常量分析和市場動態

  • 簡介
  • 全球消化性潰瘍治療藥市場金額(2020年～2030年)
  • 市場動態
    • 推動市場要素
    • 阻礙市場要素
    • 主要課題
    • 主要的機會
  • 促進因素與阻礙因素的影響分析
  • See-Saw分析

第5章 消化性潰瘍治療藥市場:各藥物(2020年～2030年)

  • 市場概要
  • 成長和收益分析:2021年對2030年
  • 市場區隔
    • 藥物
    • 質子幫浦抑制劑(PPI)
    • H2受體拮抗劑
    • 胃粘膜保護藥
    • 制酸劑
    • 前列腺素促效劑

第6章 北美的消化性潰瘍治療藥市場(2020年～2030年)

  • 市場概要
  • 消化性潰瘍治療藥市場:各藥物(2020年～2030年)
  • 消化性潰瘍治療藥市場:各地區(2020年～2030年)
    • 北美

第7章 英國、歐洲聯盟的消化性潰瘍治療藥市場(2020年～2030年)

  • 市場概要
  • 消化性潰瘍治療藥市場:各藥物(2020年～2030年)
  • 消化性潰瘍治療藥市場:各地區(2020年～2030年)
    • 英國、歐洲聯盟

第8章 亞太地區的消化性潰瘍治療藥市場(2020年～2030年)

  • 市場概要
  • 消化性潰瘍治療藥市場:各藥物(2020年～2030年)
  • 消化性潰瘍治療藥市場:各地區(2020年～2030年)
    • 亞太地區

第9章 南美的消化性潰瘍治療藥市場(2020年～2030年)

  • 市場概要
  • 消化性潰瘍治療藥市場:各藥物(2020年～2030年)
  • 消化性潰瘍治療藥市場:各地區(2020年～2030年)
    • 南美

第10章 中東、非洲的消化性潰瘍治療藥市場(2020年～2030年)

  • 市場概要
  • 消化性潰瘍治療藥市場:各藥物(2020年～2030年)
  • 消化性潰瘍治療藥市場:各地區(2020年～2030年)
    • 中東、非洲

第11章 企業簡介

  • Abbott Laboratories
  • AstraZeneca plc.
  • Cadila Healthcare Ltd.
  • Daewoong Pharmaceuticals
  • Eisai Co. Ltd.
  • PharmaKing Co. Ltd.
  • Taiho Pharmaceutical(A Otsuka Holdings)
  • Takeda Pharmaceutical
  • Yuhan Corporation
Product Code: 137608-08-22

A peptic ulcer is forms of painful sores that develops on the mucosal lining of the stomach, small intestine or lower esophagus. Increase in prevalence of H. Pylori infection, improved diagnostic techniques, easy availability of treatment medication, preferable use of peptic ulcer medication over surgery, increase in rate of smocking and over use of NSAIDs are driving the growth of peptic ulcer drugs market globally.

The report titled "Peptic Ulcer Drugs Market - Growth, Future Prospects and Competitive Analysis, 2022-2030" offers strategic insights into the overall peptic ulcer drugs market along with the market size and estimates for the duration 2020 to 2030.

Along with quantitative information, qualitative information sets and assessment tools are provided in this study for better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges and opportunities assists the readers for understanding the ongoing trends in the global peptic ulcer drugs market. In depth analysis of pipeline molecule for key products in peptic ulcer treatment, global epidemiology data for peptic ulcer have been included in report. Tools such as market positioning of key players and attractive investment proposition provide the readers with insights on the competitive scenario of the global peptic ulcer drugs market. This report concludes with company profiles section that highlights major information about the key players engaged in global peptic ulcer drugs market. In-depth competitive environment analysis and historical years (2020) market size data are also provided in the report.

Peptic ulcers are forms of painful sores that develops on the mucosal lining of the stomach, small intestine or lower esophagus. Some factors such as increase in incidence of H. pylori infections, change in lifestyles such as stress and diet pattern, increasing smoking rate, overuse of NSAIDs such as Naproxen, Ibuprofen, Aspirin, and Ketoprofen, improve diagnostics techniques and preferable used of medication over the surgeries are driving the growth of peptic ulcer drugs market globally. For the purpose of the study, the peptic ulcer drugs market is segmented on the basis of drug class such as antibiotics, proton pump inhibitors (PPIs), H2 receptor antagonists, gastric mucosal protective drugs, antacids and prostaglandin agonists. It is studied that, in the base year 2016, PPIs were major revenue generating segment because these drugs are preferably prescribed in market for treatment of peptic ulcers caused by H. pylori bacterial infection and NSAIDs. PPIs reduce the amount of acid by blocking the action of the parts of cells that produce acid and prevent further damage.

It is studied that, in the base year 2021, North America dominated the peptic ulcer drugs market in terms of revenue and it is anticipated that it will show steady growth during forecast period of 2022-2030. Factors such as large number of affected population, higher cost of treatment medication, improved diagnostic technique and upsurge in funding by the government agencies in healthcare system are driving the growth of peptic ulcer drugs market in North America. According to Centers for Disease Control and Prevention (CDC) peptic ulcer is a common illness that affects more than 6 million population in the United States annually. It is observed that currently, Europe is the second largest revenue generating regional market for peptic ulcer drugs due to higher number of affected population, improved diagnostics technique, high healthcare awareness and overuse of pain medication are driving the market growth in Europe. U.K., Germany and France are major revenue-contributing countries in Europe. It is anticipated that Asia Pacific will show highest growth rate during the forecast period due to populous countries, developing economic condition and improving healthcare infrastructure would contribute the market growth in Asia Pacific during the forecast period.

Historical & Forecast Period

This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Peptic Ulcer Drugs market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Peptic Ulcer Drugs market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Market Segmentation

Drug

Drug

Proton Pump Inhibitors (PPIs)

H2 Receptor Antagonists

Gastric Mucosal Protective Drugs

Antacids

Prostaglandin Agonists

Region Segment (2020-2030; US$ Million)

North America

U.S.

Canada

Rest of North America

UK and European Union

UK

Germany

Spain

Italy

France

Rest of Europe

Asia Pacific

China

Japan

India

Australia

South Korea

Rest of Asia Pacific

Latin America

Brazil

Mexico

Rest of Latin America

Middle East and Africa

GCC

Africa

Rest of Middle East and Africa

Global Impact of COVID-19 Segment (2020-2021; US$ Million )

Pre COVID-19 situation

Post COVID-19 situation

Key questions answered in this report:

What are the key micro and macro environmental factors that are impacting the growth of Peptic Ulcer Drugs market?

What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?

Estimated forecast and market projections up to 2030.

Which segment accounts for the fastest CAGR during the forecast period?

Which market segment holds a larger market share and why?

Are low and middle-income economies investing in the Peptic Ulcer Drugs market?

Which is the largest regional market for Peptic Ulcer Drugs market?

What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?

Which are the key trends driving Peptic Ulcer Drugs market growth?

Who are the key competitors and what are their key strategies to enhance their market presence in the Peptic Ulcer Drugs market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Peptic Ulcer Drugs Market
  • 2.2. Global Peptic Ulcer Drugs Market, By Drug, 2021 (US$ Million)
  • 2.3. Global Peptic Ulcer Drugs Market, By Geography, 2021 (US$ Million)
  • 2.4. Attractive Investment Proposition by Geography, 2021

3. Peptic Ulcer Drugs Market: Competitive Analysis

  • 3.1. Market Positioning of Key Peptic Ulcer Drugs Market Vendors
  • 3.2. Strategies Adopted by Peptic Ulcer Drugs Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2021 Versus 2030

4. Peptic Ulcer Drugs Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Peptic Ulcer Drugs Market Value, 2020 - 2030, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis

5. Peptic Ulcer Drugs Market: By Drug, 2020-2030, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2021 Versus 2030
  • 5.3. Market Segmentation
    • 5.3.1. Drug
    • 5.3.2. Proton Pump Inhibitors (PPIs)
    • 5.3.3. H2 Receptor Antagonists
    • 5.3.4. Gastric Mucosal Protective Drugs
    • 5.3.5. Antacids
    • 5.3.6. Prostaglandin Agonists

6. North America Peptic Ulcer Drugs Market, 2020-2030, USD (Million)

  • 6.1. Market Overview
  • 6.2. Peptic Ulcer Drugs Market: By Drug, 2020-2030, USD (Million)
  • 6.3.Peptic Ulcer Drugs Market: By Region, 2020-2030, USD (Million)
    • 6.3.1.North America
      • 6.3.1.1. U.S.
        • 6.3.1.1.1. Peptic Ulcer Drugs Market: By Drug, 2020-2030, USD (Million)
      • 6.3.1.2. Canada
        • 6.3.1.2.1. Peptic Ulcer Drugs Market: By Drug, 2020-2030, USD (Million)
      • 6.3.1.3. Rest of North America
        • 6.3.1.3.1. Peptic Ulcer Drugs Market: By Drug, 2020-2030, USD (Million)

7. UK and European Union Peptic Ulcer Drugs Market, 2020-2030, USD (Million)

  • 7.1. Market Overview
  • 7.2. Peptic Ulcer Drugs Market: By Drug, 2020-2030, USD (Million)
  • 7.3.Peptic Ulcer Drugs Market: By Region, 2020-2030, USD (Million)
    • 7.3.1.UK and European Union
      • 7.3.1.1. UK
        • 7.3.1.1.1. Peptic Ulcer Drugs Market: By Drug, 2020-2030, USD (Million)
      • 7.3.1.2. Germany
        • 7.3.1.2.1. Peptic Ulcer Drugs Market: By Drug, 2020-2030, USD (Million)
      • 7.3.1.3. Spain
        • 7.3.1.3.1. Peptic Ulcer Drugs Market: By Drug, 2020-2030, USD (Million)
      • 7.3.1.4. Italy
        • 7.3.1.4.1. Peptic Ulcer Drugs Market: By Drug, 2020-2030, USD (Million)
      • 7.3.1.5. France
        • 7.3.1.5.1. Peptic Ulcer Drugs Market: By Drug, 2020-2030, USD (Million)
      • 7.3.1.6. Rest of Europe
        • 7.3.1.6.1. Peptic Ulcer Drugs Market: By Drug, 2020-2030, USD (Million)

8. Asia Pacific Peptic Ulcer Drugs Market, 2020-2030, USD (Million)

  • 8.1. Market Overview
  • 8.2. Peptic Ulcer Drugs Market: By Drug, 2020-2030, USD (Million)
  • 8.3.Peptic Ulcer Drugs Market: By Region, 2020-2030, USD (Million)
    • 8.3.1.Asia Pacific
      • 8.3.1.1. China
        • 8.3.1.1.1. Peptic Ulcer Drugs Market: By Drug, 2020-2030, USD (Million)
      • 8.3.1.2. Japan
        • 8.3.1.2.1. Peptic Ulcer Drugs Market: By Drug, 2020-2030, USD (Million)
      • 8.3.1.3. India
        • 8.3.1.3.1. Peptic Ulcer Drugs Market: By Drug, 2020-2030, USD (Million)
      • 8.3.1.4. Australia
        • 8.3.1.4.1. Peptic Ulcer Drugs Market: By Drug, 2020-2030, USD (Million)
      • 8.3.1.5. South Korea
        • 8.3.1.5.1. Peptic Ulcer Drugs Market: By Drug, 2020-2030, USD (Million)
      • 8.3.1.6. Rest of Asia Pacific
        • 8.3.1.6.1. Peptic Ulcer Drugs Market: By Drug, 2020-2030, USD (Million)

9. Latin America Peptic Ulcer Drugs Market, 2020-2030, USD (Million)

  • 9.1. Market Overview
  • 9.2. Peptic Ulcer Drugs Market: By Drug, 2020-2030, USD (Million)
  • 9.3.Peptic Ulcer Drugs Market: By Region, 2020-2030, USD (Million)
    • 9.3.1.Latin America
      • 9.3.1.1. Brazil
        • 9.3.1.1.1. Peptic Ulcer Drugs Market: By Drug, 2020-2030, USD (Million)
      • 9.3.1.2. Mexico
        • 9.3.1.2.1. Peptic Ulcer Drugs Market: By Drug, 2020-2030, USD (Million)
      • 9.3.1.3. Rest of Latin America
        • 9.3.1.3.1. Peptic Ulcer Drugs Market: By Drug, 2020-2030, USD (Million)

10. Middle East and Africa Peptic Ulcer Drugs Market, 2020-2030, USD (Million)

  • 10.1. Market Overview
  • 10.2. Peptic Ulcer Drugs Market: By Drug, 2020-2030, USD (Million)
  • 10.3.Peptic Ulcer Drugs Market: By Region, 2020-2030, USD (Million)
    • 10.3.1.Middle East and Africa
      • 10.3.1.1. GCC
        • 10.3.1.1.1. Peptic Ulcer Drugs Market: By Drug, 2020-2030, USD (Million)
      • 10.3.1.2. Africa
        • 10.3.1.2.1. Peptic Ulcer Drugs Market: By Drug, 2020-2030, USD (Million)
      • 10.3.1.3. Rest of Middle East and Africa
        • 10.3.1.3.1. Peptic Ulcer Drugs Market: By Drug, 2020-2030, USD (Million)

11. Company Profile

  • 11.1. Abbott Laboratories
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Portfolio
    • 11.1.4. Strategic Initiatives
  • 11.2. AstraZeneca plc.
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Portfolio
    • 11.2.4. Strategic Initiatives
  • 11.3. Cadila Healthcare Ltd.
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Portfolio
    • 11.3.4. Strategic Initiatives
  • 11.4. Daewoong Pharmaceuticals
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Portfolio
    • 11.4.4. Strategic Initiatives
  • 11.5. Eisai Co. Ltd.
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Portfolio
    • 11.5.4. Strategic Initiatives
  • 11.6. PharmaKing Co. Ltd.
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Portfolio
    • 11.6.4. Strategic Initiatives
  • 11.7. Taiho Pharmaceutical (A Otsuka Holdings)
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Portfolio
    • 11.7.4. Strategic Initiatives
  • 11.8. Takeda Pharmaceutical
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Portfolio
    • 11.8.4. Strategic Initiatives
  • 11.9. Yuhan Corporation
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Portfolio
    • 11.9.4. Strategic Initiatives

List of Tables

  • TABLE 1 Global Peptic Ulcer Drugs Market By Drug, 2020-2030, USD (Million)
  • TABLE 2 North America Peptic Ulcer Drugs Market By Drug, 2020-2030, USD (Million)
  • TABLE 3 U.S. Peptic Ulcer Drugs Market By Drug, 2020-2030, USD (Million)
  • TABLE 4 Canada Peptic Ulcer Drugs Market By Drug, 2020-2030, USD (Million)
  • TABLE 5 Rest of North America Peptic Ulcer Drugs Market By Drug, 2020-2030, USD (Million)
  • TABLE 6 UK and European Union Peptic Ulcer Drugs Market By Drug, 2020-2030, USD (Million)
  • TABLE 7 UK Peptic Ulcer Drugs Market By Drug, 2020-2030, USD (Million)
  • TABLE 8 Germany Peptic Ulcer Drugs Market By Drug, 2020-2030, USD (Million)
  • TABLE 9 Spain Peptic Ulcer Drugs Market By Drug, 2020-2030, USD (Million)
  • TABLE 10 Italy Peptic Ulcer Drugs Market By Drug, 2020-2030, USD (Million)
  • TABLE 11 France Peptic Ulcer Drugs Market By Drug, 2020-2030, USD (Million)
  • TABLE 12 Rest of Europe Peptic Ulcer Drugs Market By Drug, 2020-2030, USD (Million)
  • TABLE 13 Asia Peptic Ulcer Drugs Market By Drug, 2020-2030, USD (Million)
  • TABLE 14 China Peptic Ulcer Drugs Market By Drug, 2020-2030, USD (Million)
  • TABLE 15 Japan Peptic Ulcer Drugs Market By Drug, 2020-2030, USD (Million)
  • TABLE 16 India Peptic Ulcer Drugs Market By Drug, 2020-2030, USD (Million)
  • TABLE 17 Australia Peptic Ulcer Drugs Market By Drug, 2020-2030, USD (Million)
  • TABLE 18 South Korea Peptic Ulcer Drugs Market By Drug, 2020-2030, USD (Million)
  • TABLE 19 Latin America Peptic Ulcer Drugs Market By Drug, 2020-2030, USD (Million)
  • TABLE 20 Brazil Peptic Ulcer Drugs Market By Drug, 2020-2030, USD (Million)
  • TABLE 21 Mexico Peptic Ulcer Drugs Market By Drug, 2020-2030, USD (Million)
  • TABLE 22 Rest of Latin America Peptic Ulcer Drugs Market By Drug, 2020-2030, USD (Million)
  • TABLE 23 Middle East and Africa Peptic Ulcer Drugs Market By Drug, 2020-2030, USD (Million)
  • TABLE 24 GCC Peptic Ulcer Drugs Market By Drug, 2020-2030, USD (Million)
  • TABLE 25 Africa Peptic Ulcer Drugs Market By Drug, 2020-2030, USD (Million)
  • TABLE 26 Rest of Middle East and Africa Peptic Ulcer Drugs Market By Drug, 2020-2030, USD (Million)

List of Figures

  • FIG. 1 Global Peptic Ulcer Drugs Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Peptic Ulcer Drugs Market: Quality Assurance
  • FIG. 5 Global Peptic Ulcer Drugs Market, By Drug, 2021
  • FIG. 6 Global Peptic Ulcer Drugs Market, By Geography, 2021
  • FIG. 7 Market Geographical Opportunity Matrix - Global Peptic Ulcer Drugs Market, 2021
  • FIG. 8 Market Positioning of Key Peptic Ulcer Drugs Market Players, 2021
  • FIG. 9 Global Peptic Ulcer Drugs Market - Tier Analysis - Percentage of Revenues by Tier Level, 2021 Versus 2030
  • FIG. 10 Global Peptic Ulcer Drugs Market, By Drug, 2021 Vs 2030, %
  • FIG. 11 U.S. Peptic Ulcer Drugs Market (US$ Million), 2020 - 2030
  • FIG. 12 Canada Peptic Ulcer Drugs Market (US$ Million), 2020 - 2030
  • FIG. 13 Rest of North America Peptic Ulcer Drugs Market (US$ Million), 2020 - 2030
  • FIG. 14 UK Peptic Ulcer Drugs Market (US$ Million), 2020 - 2030
  • FIG. 15 Germany Peptic Ulcer Drugs Market (US$ Million), 2020 - 2030
  • FIG. 16 Spain Peptic Ulcer Drugs Market (US$ Million), 2020 - 2030
  • FIG. 17 Italy Peptic Ulcer Drugs Market (US$ Million), 2020 - 2030
  • FIG. 18 France Peptic Ulcer Drugs Market (US$ Million), 2020 - 2030
  • FIG. 19 Rest of Europe Peptic Ulcer Drugs Market (US$ Million), 2020 - 2030
  • FIG. 20 China Peptic Ulcer Drugs Market (US$ Million), 2020 - 2030
  • FIG. 21 Japan Peptic Ulcer Drugs Market (US$ Million), 2020 - 2030
  • FIG. 22 India Peptic Ulcer Drugs Market (US$ Million), 2020 - 2030
  • FIG. 23 Australia Peptic Ulcer Drugs Market (US$ Million), 2020 - 2030
  • FIG. 24 South Korea Peptic Ulcer Drugs Market (US$ Million), 2020 - 2030
  • FIG. 25 Rest of Asia Peptic Ulcer Drugs Market (US$ Million), 2020 - 2030
  • FIG. 26 Brazil Peptic Ulcer Drugs Market (US$ Million), 2020 - 2030
  • FIG. 27 Mexico Peptic Ulcer Drugs Market (US$ Million), 2020 - 2030
  • FIG. 28 Rest of Latin America Peptic Ulcer Drugs Market (US$ Million), 2020 - 2030
  • FIG. 29 GCC Peptic Ulcer Drugs Market (US$ Million), 2020 - 2030
  • FIG. 30 Africa Peptic Ulcer Drugs Market (US$ Million), 2020 - 2030
  • FIG. 31 Rest of Middle East and Africa Peptic Ulcer Drugs Market (US$ Million), 2020 - 2030